Sleep Science — 2026-10-13
This week’s sleep science landscape is dominated by emerging clinical evidence for insomnia treatments and a critical look at the limitations of consumer sleep tracking devices. Key developments include new pediatric data for the dual orexin receptor antagonist daridorexant and expert reviews highlighting accuracy issues in popular wearables.















